BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 81 filers reported holding BELLICUM PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $6,993,000 | -11.3% | 513,443 | +29.5% | 0.00% | 0.0% |
| Q3 2016 | $7,888,000 | +83.9% | 396,384 | +19.8% | 0.00% | 0.0% |
| Q2 2016 | $4,290,000 | +106.2% | 331,003 | +48.8% | 0.00% | – |
| Q1 2016 | $2,080,000 | -54.2% | 222,481 | -0.8% | 0.00% | -100.0% |
| Q4 2015 | $4,546,000 | +41.7% | 224,252 | +1.5% | 0.00% | 0.0% |
| Q3 2015 | $3,209,000 | +11.5% | 220,884 | +63.2% | 0.00% | – |
| Q2 2015 | $2,879,000 | +27.2% | 135,349 | +38.5% | 0.00% | – |
| Q1 2015 | $2,264,000 | – | 97,708 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtus ETF Advisers LLC | 15,086 | $306,000 | 0.84% |
| Baker Brothers Advisors | 4,865,647 | $98,627,000 | 0.82% |
| Cormorant Asset Management, LP | 300,000 | $6,081,000 | 0.73% |
| SPHERA FUNDS MANAGEMENT LTD. | 231,515 | $4,693,000 | 0.69% |
| QVT Financial LP | 340,986 | $6,912,000 | 0.39% |
| Graticule Asia Macro Advisors LLC | 87,000 | $1,763,000 | 0.29% |
| Hatteras Investment Partners, LP | 10,410 | $211,000 | 0.28% |
| MCDANIEL TERRY & CO | 33,836 | $686,000 | 0.18% |
| Highlander Capital Management, LLC | 6,500 | $132,000 | 0.12% |
| EverPoint Asset Management, LLC | 265,000 | $5,372,000 | 0.11% |